Live Breaking News & Updates on Scientific Session

Stay updated with breaking news from Scientific session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

American Society of Echocardiography Scientific Sessions ASE 2024 Program Highlights

American Society of Echocardiography Scientific Sessions ASE 2024 Program Highlights
dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.

United-states , Chicago , Illinois , Texas , American , Federico-asch , Richarde-kerber , Lloyd-huck , Linda-gillam , Arthure-weyman-young , Julius-gardin , Eric-kruse

Novel PCSK9 Inhibitor Reduced LDL by 50%

Lerodalcibep, a third-generation PCSK9 inhibitor, reduced LDL by more than 50% vs placebo in patients with or at a high risk for CVD in the phase 3 LIBerate-HR trial. ....

South-africa , United-states , Johannesburg , Gauteng , American , Eric-klug , American-college-of-cardiology , Division-of-cardiology , University-of-the-witwatersrand , European-society-of-cardiology , Prevention-of-cardiovascular-disease-council , Virginia-commonwealth-university-school-of-pharmacy

Tirzepatide Demonstrates Reduction in Sleep Apnea-Relate Events

Eli Lilly and Company will submit results of the study to support tirzepatide (Zepbound) for treatment of obstructive sleep apnea later this year. ....

Australia , Taiwan , Czech-republic , Japan , China , United-states , Mexico , Brazil , Germany , American , Czechia , Ttirzepatide-zepbound

Complete Revasc Not Superior to Culprit-Only PCI After MI

In patients with STEMI and multivessel disease, FFR-guided complete nonculprit revascularization did not reduce events vs culprit lesion-only PCI in the FULL-REVASC trial. ....

California , United-states , Newcastle-upon-tyne , United-kingdom , Stanford-university , Danderyd , Stockholm , Sweden , Vijay-kunadian , William-fearon , Stanford-university-school-of-medicine , Newcastle-university

Adding ACEI to Chemotherapy Does Not Prevent Cardiotoxicity

The PROACT trial assessing enalapril in patients with cancer undergoing chemotherapy showed this approach did not affect cardiac function or the rate of cardiac injury. ....

New-york , United-states , David-austin , Anita-deswal , American-college-of-cardiology , National-health-service , University-of-texas , James-cook-university-hospital , Department-of-cardiology , Division-of-internal-medicine , Icahn-school-of-medicine-at-mount-sinai , Academic-cardiovascular-unit